DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Acular LS (Ketorolac Tromethamine Ophthalmic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

ACULAR LS ® ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

DOSAGE AND ADMINISTRATION

The recommended dose of ACULAR LS® ophthalmic solution is one drop four times a day in the operated eye as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery.

Ketorolac tromethamine ophthalmic solution has been safely administered in conjunction with other ophthalmic medications such as antibiotics, beta blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.

HOW SUPPLIED

ACULAR LS® (ketorolac tromethamine ophthalmic solution) 0.4% is supplied sterile in an opaque white LDPE plastic bottle with a white dropper with a gray high impact polystyrene (HIPS) cap as follows:

5 mL in 10 mL bottle- NDC 0023-9277-05

Note: Store at 15°C – 25°C (59°F- 77°F).

Rx only

Revised: 12/2008

U.S. Pat. 5,110,493
©2008 Allergan, Inc., Irvine, CA 92612, U.S.A.
® Marks owned by Allergan, Inc.

ACULAR LS® is a trademark of Roche Palo Alto LLC

This product is manufactured and distributed by Allergan, Inc. under license from its developer, Roche Palo Alto LLC, Palo Alto, California, U.S.A.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012